Order Online
Contact Us


Bathroom assists
Children/ Pediatric
Cushions
Daily Living Aids
Diabetes Care
Diagnostic Products
Diet Supplements
Electrotherapy
Exercise/ Fitness
Impotence
Incontinence
Liftchairs
Maternity Care
Orthopedics
Osthonomy Care
Oxygen Therapy
Patient Care
Personal Care
Power Scooters
Skin Care
Surgical Supplies
Urologicals/Catheters
Walkers/ Canes
Wheelchairs
Wound Care


FDA approves four new diabetes drug treatments.

Diabetes is identified to be one of the most life-threatening diseases in the world. It is an illness that occurs when the pancreas has produced only a small amount of insulin, which then gives rise to the body?s inability to break down sugar into a functional energy.

Numerous treatments were developed to help alleviate the distress brought about by this disease. Most of the drugs which have been formulated were submitted first to the Food and Drug Administration (FDA) for approval. And when approved by the FDA, the drugs are recommended for patient treatment.

Recently, four new drug treatments have been approved by the FDA. The said drug treatments are the: Glucobay (Acarbose), Humalog Insulin (Lispro), Byetta, and Symlin. These drugs are generally made available to increase insulin sensitivity of diabetes.

Glucobay (Acarbose) is specifically designed to inhibit the growth of enzymes responsible for the splitting of complex carbohydrate into monosaccharide elements ready for assimilation. This medicine can retard the digestion of sugars and starches, which makes it an ideal solution to reduce high level of sugars in your body.

Humalog Insulin (Lispro) is a human analog that is mainly characterized by insulin therapy. It is approved by FDA for pediatric and geriatric treatments. This medication should be taken within fifteen minutes prior to or subsequent to a meal. This way the insulin is hastened to hold back the blood sugar levels after a meal.

Byetta is chemically called as exenatide. It is described as an incretin mimetic agent and is deemed as a good alternative treatment for insulin therapy. On the other hand, Symlin is suitable to those who suffer from type 1 as well as type 2 diabetes. This injectable drug is usually utilized as part of the insulin therapy for those patients with inadequate ability to restrain their blood-glucose levels.

At present, more and more drug treatments for diabetics are introduced to the society. Patients can breathe much freely now as new options to combat diabetes are brought into fruition. In effect, coping with your blood sugar levels is attained more prolifically.